Back

Vericiguat and reverse ventricular remodeling in patients with chronic HFrEF and recent heart failure worsening

19 May 2025 (09:53 - 10:46)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (3) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Tine Bajec

University Clinical Centre Ljubljana, Ljubljana (Slovenia)

8 More presentations in this session

Presentation thumbnail
Assessment of pharmacotherapy modifications during the treatment of episode of acutely decompensated heart failure - the HEROES study.
Doctor A. Galas (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Optimising heart failure therapy: potassium binders and the initiation and titration of mineralocorticoid receptor antagonists
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
Doctor S. Fox (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Performance of mortality risk scores in advanced heart failure patients: a retrospective cohort study
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Diuretic discontinuation after heart failure hospitalisation
Doctor J. Matejka (Pardubice, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (3)

The Event

Event poster

Heart Failure 2025

19 May 2025 09:53 CET
You may be interested in
thumbnail
Congress Presentation
Role of Vericiguat on clinical, echocardiographic and comprehensive geriatric assessment parameters in elderly patients with worsening Heart Failure
thumbnail
Congress Presentation
Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting
thumbnail
Congress Presentation
Cardiac reverse remodeling in the trial of accelerated guideline-directed medical therapy for Heart Failure (TEAM-HF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources